Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation

Lemasters JJ (2005) Dying a thousand deaths: redundant pathways from different organelles to apoptosis and necrosis. Gastroenterology 129:351–360 Servais H, Van Der Smissen P, Thirion G et al (2005) Gentamicin-induced apoptosis in LLC-PK1 cells: involvement of lysosomes and mitochondria. Toxicol Appl Pharmacol 206:321–333 Lee RH, Song JM, Park MY, Kang SK, Kim YK, Jung JS (2001) Cisplatin-induced apoptosis by translocation of endogenous Bax in mouse collecting duct cells. Biochem Pharmacol 62:1013–1023 Raffray M, Cohen GM (1997) Apoptosis and necrosis in toxicology: a continuum or distinct modes of cell death? Pharmacol Ther 75:153–177 Hauser P, Oberbauer R (2002) Tubular apoptosis in the pathophysiology of renal disease. Wien Klin Wochenschr 114:671–677 Cummings J, Ward TH, Ranson M, Dive C (2004) Apoptosis pathway-targeted drugs–from the bench to the clinic. Biochim Biophys Acta 1705:53–66 Broker LE, Kruyt FA, Giaccone G (2005) Cell death independent of caspases: a review. Clin Cancer Res 11:3155–3162 Lavrik IN, Golks A, Krammer PH (2005) Caspases: pharmacological manipulation of cell death. J Clin Invest 115:2665–2672 Kim R, Emi M, Tanabe K (2005) Role of mitochondria as the gardens of cell death. Cancer Chemother Pharmacol 57:545–553 Daugas E, Nochy D, Ravagnan L et al (2000) Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett 476:118–123 Ekert PG, Vaux DL (2005) The mitochondrial death squad: hardened killers or innocent bystanders? Curr Opin Cell Biol 17:626–630 Schafer ZT, Kornbluth S (2006) The apoptosome: physiological, developmental, and pathological modes of regulation. Dev Cell 10:549–561 Lalier L, Cartron PF, Juin P et al (2007) Bax activation and mitochondrial insertion during apoptosis. Apoptosis 12:887–896 Ott M, Zhivotovsky B, Orrenius S (2007) Role of cardiolipin in cytochrome c release from mitochondria. Cell Death Differ 14:1243–1247 Iverson SL, Orrenius S (2004) The cardiolipin-cytochrome c interaction and the mitochondrial regulation of apoptosis. Arch Biochem Biophys 423:37–46 Scorrano L, Korsmeyer SJ (2003) Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem Biophys Res Commun 304:437–444 Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC (1994) Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 145:1323–1336 Kuwana T, Newmeyer DD (2003) Bcl-2-family proteins and the role of mitochondria in apoptosis. Curr Opin Cell Biol 15:691–699 Robertson JD, Enoksson M, Suomela M, Zhivotovsky B, Orrenius S (2002) Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J Biol Chem 277:29803–29809 Liston P, Fong WG, Korneluk RG (2003) The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 22:8568–8580 Ruchalski K, Mao H, Li Z et al (2006) Distinct hsp70 domains mediate apoptosis-inducing factor release and nuclear accumulation. J Biol Chem 281:7873–7880 Garrido C, Brunet M, Didelot C, Zermati Y, Schmitt E, Kroemer G (2006) Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle 5:2592–2601 Chandler D, el Naggar AK, Brisbay S, Redline RW, McDonnell TJ (1994) Apoptosis and expression of the bcl-2 proto-oncogene in the fetal and adult human kidney: evidence for the contribution of bcl-2 expression to renal carcinogenesis. Hum Pathol 25:789–796 Oberbauer R, Rohrmoser M, Regele H, Muhlbacher F, Mayer G (1999) Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function. J Am Soc Nephrol 10:2006–2013 Kroning R, Katz D, Lichtenstein AK, Nagami GT (1999) Differential effects of cisplatin in proximal and distal renal tubule epithelial cell lines. Br J Cancer 79:293–299 Tarze A, Deniaud A, Le Bras M et al (2007) GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization. Oncogene 26:2606–2620 Servais H, Jossin Y, Van Bambeke F, Tulkens PM, Mingeot-Leclercq MP (2006) Gentamicin causes apoptosis at low concentrations in renal LLC-PK1 cells subjected to electroporation. Antimicrob Agents Chemother 50:1213–1221 Justo P, Lorz C, Sanz A, Egido J, Ortiz A (2003) Intracellular mechanisms of cyclosporin A-induced tubular cell apoptosis. J Am Soc Nephrol 14:3072–3080 Wei Q, Dong G, Franklin J, Dong Z (2007) The pathological role of Bax in cisplatin nephrotoxicity. Kidney Int 72:53–62 Peherstorfer E, Mayer B, Boehm S et al (2002) Effects of microinjection of synthetic Bcl-2 domain peptides on apoptosis of renal tubular epithelial cells. Am J Physiol Renal Physiol 283:F190–F196 Sawada M, Hayes P, Matsuyama S (2003) Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70. Nat Cell Biol 5:352–357 Retractions (2007). Nat Cell Biol 9:480 Justo P, Sanz AB, Egido J, Ortiz A (2005) 3,4-Dideoxyglucosone-3-ene induces apoptosis in renal tubular epithelial cells. Diabetes 54:2424–2429 Orlowski RZ (1999) The role of the ubiquitin-proteasome pathway in apoptosis. Cell Death Differ 6:303–313 Zhu H, Zhang L, Dong F et al (2005) Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors. Oncogene 24:4993–4999 Fribley A, Wang CY (2006) Proteasome inhibitor induces apoptosis through induction of endoplasmic reticulum stress. Cancer Biol Ther 5:745–748 Zavrski I, Kleeberg L, Kaiser M et al (2007) Proteasome as an emerging therapeutic target in cancer. Curr Pharm Des 13:471–485 Chwieralski CE, Welte T, Buhling F (2006) Cathepsin-regulated apoptosis. Apoptosis 11:143–149 Yuan XM, Li W, Dalen H et al (2002) Lysosomal destabilization in p53-induced apoptosis. Proc Natl Acad Sci USA 99:6286–6291 Cao X, Deng X, May WS (2003) Cleavage of Bax to p18 Bax accelerates stress-induced apoptosis, and a cathepsin-like protease may rapidly degrade p18 Bax. Blood 102:2605–2614 Szegezdi E, Logue SE, Gorman AM, Samali A (2006) Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 7:880–885 Goetz JG, Nabi IR (2006) Interaction of the smooth endoplasmic reticulum and mitochondria. Biochem Soc Trans 34:370–373 Hetz C, Bernasconi P, Fisher J et al (2006) Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1alpha. Science 312:572–576 Mathai JP, Germain M, Shore GC (2005) BH3-only BIK regulates BAX,BAK-dependent release of Ca2+ from endoplasmic reticulum stores and mitochondrial apoptosis during stress-induced cell death. J Biol Chem 280:23829–23836 Zinszner H, Kuroda M, Wang X et al (1998) CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 12:982–995 Erdal H, Berndtsson M, Castro J, Brunk U, Shoshan MC, Linder S (2005) Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. Proc Natl Acad Sci USA 102:192–197 Machamer CE (2003) Golgi disassembly in apoptosis: cause or effect? Trends Cell Biol 13:279–281 Hicks SW, Machamer CE (2005) Golgi structure in stress sensing and apoptosis. Biochim Biophys Acta 1744:406–414 Ortiz A, Lorz C, Catalan MP et al (2000) Expression of apoptosis regulatory proteins in tubular epithelium stressed in culture or following acute renal failure. Kidney Int 57:969–981 Kataoka T (2005) The caspase-8 modulator c-FLIP. Crit Rev Immunol 25:31–58 Lorz C, Justo P, Sanz AB, Egido J, Ortiz A (2005) Role of Bcl-xL in paracetamol-induced tubular epithelial cell death. Kidney Int 67:592–601 Modjtahedi N, Giordanetto F, Madeo F, Kroemer G (2006) Apoptosis-inducing factor: vital and lethal. Trends Cell Biol 16:264–272 Mao WP, Ye JL, Guan ZB et al (2007) Cadmium induces apoptosis in human embryonic kidney (HEK) 293 cells by caspase-dependent and -independent pathways acting on mitochondria. Toxicol In Vitro 21:343–354 Kagami S, Kondo S (2004) Beta1-integrins and glomerular injury. J Med Invest 51:1–13 Bijian K, Takano T, Papillon J, Khadir A, Cybulsky AV (2004) Extracellular matrix regulates glomerular epithelial cell survival and proliferation. Am J Physiol Renal Physiol 286:F255–F266 Dutta J, Fan Y, Gupta N, Fan G, Gelinas C (2006) Current insights into the regulation of programmed cell death by NF-kappaB. Oncogene 25:6800–6816 Park SJ, Jeong KS (2004) Cell-type-specific activation of mitogen-activated protein kinases in PAN-induced progressive renal disease in rats. Biochem Biophys Res Commun 323:1–8 Awazu M, Omori S, Hida M (2002) MAP kinase in renal development. Nephrol Dial Transplant 17(Suppl 9):5–7 Sen P, Mukherjee S, Ray D, Raha S (2003) Involvement of the Akt/PKB signaling pathway with disease processes. Mol Cell Biochem 253:241–246 O’Dea EL, Barken D, Peralta RQ et al (2007) A homeostatic model of IkappaB metabolism to control constitutive NF-kappaB activity. Mol Syst Biol 3:111 Heikaus S, Casliskan E, Mahotka C, Gabbert HE, Ramp U (2007) Differential gene expression in anticancer drug- and TRAIL-mediated apoptosis in renal cell carcinomas. Apoptosis 12:1645–1657 Shetty S, Gladden JB, Henson ES et al (2002) Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines. Apoptosis 7:413–420 Efeyan A, Serrano M (2007) p53: guardian of the genome and policeman of the oncogenes. Cell Cycle 6:1006–1010 Vousden KH, Lane DP (2007) p53 in health and disease. Nat Rev Mol Cell Biol 8:275–283 Ries F, Klastersky J (1986) Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. Am J Kidney Dis 8:368–379 Kuhlmann MK, Burkhardt G, Kohler H (1997) Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol Dial Transplant 12:2478–2480 Endo T, Kimura O, Sakata M (2000) Carrier-mediated uptake of cisplatin by the OK renal epithelial cell line. Toxicology 146:187–195 Ban M, Hettich D, Huguet N (1994) Nephrotoxicity mechanism of cis-platinum(II) diamine dichloride in mice. Toxicol Lett 71:161–168 Huang Q, Dunn RT, Jayadev S et al (2001) Assessment of cisplatin-induced nephrotoxicity by microarray technology. Toxicol Sci 63:196–207 Arany I, Safirstein RL (2003) Cisplatin nephrotoxicity. Semin Nephrol 23:460–464 Arany I, Megyesi JK, Kaneto H, Price PM, Safirstein RL (2004) Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells. Am J Physiol Renal Physiol 287:F543–F549 Dobyan DC, Levi J, Jacobs C, Kosek J, Weiner MW (1980) Mechanism of cis-platinum nephrotoxicity. II. Morphologic observations. J Pharmacol Exp Ther 213:551–556 Kaushal GP, Kaushal V, Hong X, Shah SV (2001) Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells. Kidney Int 60:1726–1736 Wei Q, Dong G, Yang T, Megyesi J, Price PM, Dong Z (2007) Activation and Involvement of p53 in Cisplatin-induced Nephrotoxicity. Am J Physiol Renal Physiol 293:F1282–F1291 Jiang M, Pabla N, Murphy RF et al (2007) Nutlin-3 protects kidney cells during cisplatin therapy by suppressing Bax/Bak activation. J Biol Chem 282:2636–2645 Wang J, Pabla N, Wang CY, Wang W, Schoenlein PV, Dong Z (2006) Caspase-mediated cleavage of ATM during cisplatin-induced tubular cell apoptosis: inactivation of its kinase activity toward p53. Am J Physiol Renal Physiol 291:F1300–F1307 Dippold WG, Jay G, DeLeo AB, Khoury G, Old LJ (1981) p53 transformation-related protein: detection by monoclonal antibody in mouse and human cells. Proc Natl Acad Sci USA 78:1695–1699 Jiang M, Wei Q, Wang J et al (2006) Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis. Oncogene 25:4056–4066 Seth R, Yang C, Kaushal V, Shah SV, Kaushal GP (2005) p53-dependent caspase-2 activation in mitochondrial release of apoptosis-inducing factor and its role in renal tubular epithelial cell injury. J Biol Chem 280:31230–31239 Moll UM, Wolff S, Speidel D, Deppert W (2005) Transcription-independent pro-apoptotic functions of p53. Curr Opin Cell Biol 17:631–636 Ramesh G, Reeves WB (2005) p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. Am J Physiol Renal Physiol 289:F166–F174 Kim YK, Jung JS, Lee SH, Kim YW (1997) Effects of antioxidants and Ca2+ in cisplatin-induced cell injury in rabbit renal cortical slices. Toxicol Appl Pharmacol 146:261–269 Zhou H, Kato A, Yasuda H et al (2004) The induction of cell cycle regulatory and DNA repair proteins in cisplatin-induced acute renal failure. Toxicol Appl Pharmacol 200:111–120 Price PM, Yu F, Kaldis P et al (2006) Dependence of cisplatin-induced cell death in vitro and in vivo on cyclin-dependent kinase 2. J Am Soc Nephrol 17:2434–2442 Yu F, Megyesi J, Safirstein RL, Price PM (2007) Involvement of the CDK2-E2F1 pathway in cisplatin cytotoxicity in vitro and in vivo. Am J Physiol Renal Physiol 293:F52–F59 Momekov G, Konstantinov S, Topashka-Ancheva M, Bakalova A, Arpadjan S, Karaivanova M (2007) Cellular pharmacology, antineoplastic activity and low in vivo toxicity of a carboxylato-bridged platinum(II) complex bis(acetato)diammine-bis-micro-acetato diplatinum(II) dihydrate. Med Chem 3:157–165 Mingeot-Leclercq MP, Tulkens PM (1999) Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother 43:1003–1012 Fabre J, Rudhardt M, Blanchard P, Regamey C (1976) Persistence of sisomicin and gentamicin in renal cortex and medulla compared with other organs and serum of rats. Kidney Int 10:444–449 Vandewalle A, Farman N, Morin JP, Fillastre JP, Hatt PY, Bonvalet JP (1981) Gentamicin incorporation along the nephron: autoradiographic study on isolated tubules. Kidney Int 19:529–539 Sastrasinh M, Knauss TC, Weinberg JM, Humes HD (1982) Identification of the aminoglycoside binding site in rat renal brush border membranes. J Pharmacol Exp Ther 222:350–358 Moestrup SK, Cui S, Vorum H et al (1995) Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. J Clin Invest 96:1404–1413 Silverblatt FJ, Kuehn C (1979) Autoradiography of gentamicin uptake by the rat proximal tubule cell. Kidney Int 15:335–345 Giurgea-Marion L, Toubeau G, Laurent G, Heuson-Stiennon JA, Tulkens PM (1986) Impairment of lysosome-pinocytic vesicle fusion in rat kidney proximal tubules after treatment with gentamicin at low doses. Toxicol Appl Pharmacol 86:271–285 El Mouedden M, Laurent G, Mingeot-Leclercq MP, Taper HS, Cumps J, Tulkens PM (2000) Apoptosis in renal proximal tubules of rats treated with low doses of aminoglycosides. Antimicrob Agents Chemother 44:665–675 El Mouedden M, Laurent G, Mingeot-Leclercq MP, Tulkens PM (2000) Gentamicin-induced apoptosis in renal cell lines and embryonic rat fibroblasts. Toxicol Sci 56:229–239 Sandoval RM, Molitoris BA (2004) Gentamicin traffics retrograde through the secretory pathway and is released in the cytosol via the endoplasmic reticulum. Am J Physiol Renal Physiol 286:F617–F624 Mather M, Rottenberg H (2001) Polycations induce the release of soluble intermembrane mitochondrial proteins. Biochim Biophys Acta 1503:357–368 Horibe T, Matsui H, Tanaka M et al (2004) Gentamicin binds to the lectin site of calreticulin and inhibits its chaperone activity. Biochem Biophys Res Commun 323:281–287 Lesniak W, Pecoraro VL, Schacht J (2005) Ternary complexes of gentamicin with iron and lipid catalyze formation of reactive oxygen species. Chem Res Toxicol 18:357–364 Li C, Lim SW, Sun BK, Yang CW (2004) Chronic cyclosporine nephrotoxicity: new insights and preventive strategies. Yonsei Med J 45:1004–1016 Fellstrom B (2004) Cyclosporine nephrotoxicity. Transplant Proc 36:220S–223S Stratta P, Canavese C, Quaglia M et al (2005) Posttransplantation chronic renal damage in nonrenal transplant recipients. Kidney Int 68:1453–1463 Olyaei AJ, de Mattos AM, Bennett WM (2001) Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Curr Opin Crit Care 7:384–389 Dieperink H, Kemp E, Leyssac PP et al (1986) Ketoconazole and cyclosporine A: combined effects on rat renal function and on serum and tissue cyclosporine A concentration. Clin Nephrol 25(Suppl 1):S137–S143 del Moral RG, Olmo A, Aguilar M, O’Valle F (1998) P glycoprotein: a new mechanism to control drug-induced nephrotoxicity. Exp Nephrol 6:89–97 Hauser IA, Schaeffeler E, Gauer S et al (2005) ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation. J Am Soc Nephrol 16:1501–1511 Thomas SE, Andoh TF, Pichler RH et al (1998) Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int 53:897–908 Shimizu H, Takahashi M, Takeda S et al (2004) Conversion from cyclosporine A to mycophenolate mofetil protects recipient kidney and prevents intimal hyperplasia in rat aortic allografts. Transpl Immunol 13:219–227 Lee SY, Jo SK, Cho WY, Kim HK, Won NH (2004) The effect of alpha-melanocyte-stimulating hormone on renal tubular cell apoptosis and tubulointerstitial fibrosis in cyclosporine A nephrotoxicity. Transplantation 78:1756–1764 Ortiz A, Lorz C, Catalan M, Ortiz A, Coca S, Egido J (1998) Cyclosporine A induces apoptosis in murine tubular epithelial cells: role of caspases. Kidney Int Suppl 68:S25–S29 Amore A, Emancipator SN, Cirina P et al (2000) Nitric oxide mediates cyclosporine-induced apoptosis in cultured renal cells. Kidney Int 57:1549–1559 Jeon SH, Piao YJ, Choi KJ et al (2005) Prednisolone suppresses cyclosporin A-induced apoptosis but not cell cycle arrest in MDCK cells. Arch Biochem Biophys 435:382–392 Han SY, Chang EJ, Choi HJ et al (2006) Apoptosis by cyclosporine in mesangial cells. Transplant Proc 38:2244–2246 Yang CW, Faulkner GR, Wahba IM et al (2002) Expression of apoptosis-related genes in chronic cyclosporine nephrotoxicity in mice. Am J Transplant 2:391–399 Shihab FS, Bennett WM, Yi H, Andoh TF (2005) Effect of pirfenidone on apoptosis-regulatory genes in chronic cyclosporine nephrotoxicity. Transplantation 79:419–426 Kim SI, Song HY, Hwang JH et al (2000) Cyclosporine nephrotoxicity: the mechanisms of cell injury by cyclosporine A in renal proximal tubular cells. Transplant Proc 32:1621–1622 Fischer U, Schulze-Osthoff K (2005) New approaches and therapeutics targeting apoptosis in disease. Pharmacol Rev 57:187–215 Lorz C, Benito-Martin A, Justo P et al (2006) Modulation of renal tubular cell survival: where is the evidence? Curr Med Chem 13:449–454 Ciarimboli G, Ludwig T, Lang D et al (2005) Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2. Am J Pathol 167:1477–1484 Cihlar T, Ho ES, Lin DC, Mulato AS (2001) Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs. Nucleosides Nucleotides Nucleic Acids 20:641–648 Nagai J, Takano M (2004) Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity. Drug Metab Pharmacokinet 19:159–170 Takamoto K, Kawada M, Ikeda D, Yoshida M (2005) Apolipoprotein E3 (apoE3) safeguards pig proximal tubular LLC-PK1 cells against reduction in SGLT1 activity induced by gentamicin C. Biochim Biophys Acta 1722:247–253 Perez M, Castilla M, Torres AM, Lazaro JA, Sarmiento E, Tejedor A (2004) Inhibition of brush border dipeptidase with cilastatin reduces toxic accumulation of cyclosporin A in kidney proximal tubule epithelial cells. Nephrol Dial Transplant 19:2445–2455 Pingle SC, Mishra S, Marcuzzi A et al (2004) Osmotic diuretics induce adenosine A1 receptor expression and protect renal proximal tubular epithelial cells against cisplatin-mediated apoptosis. J Biol Chem 279:43157–43167 Letai A (2005) Pharmacological manipulation of Bcl-2 family members to control cell death. J Clin Invest 115:2648–2655 Gama V, Yoshida T, Gomez JA et al (2006) Involvement of the ubiquitin pathway in decreasing Ku70 levels in response to drug-induced apoptosis. Exp Cell Res 312:488–499 Wang J, Wei Q, Wang CY, Hill WD, Hess DC, Dong Z (2004) Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem 279:19948–19954 Wada T, Pippin JW, Marshall CB, Griffin SV, Shankland SJ (2005) Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins. J Am Soc Nephrol 16:2615–2625 Wilson C, Foster GH, Bitzan M (2005) Silencing of Bak ameliorates apoptosis of human proximal tubular epithelial cells by Escherichia coli-derived Shiga toxin 2. Infection 33:362–367 Zheng X, Zhang X, Sun H et al (2006) Protection of renal ischemia injury using combination gene silencing of complement 3 and caspase 3 genes. Transplantation 82:1781–1786 Du C, Wang S, Diao H, Guan Q, Zhong R, Jevnikar AM (2006) Increasing resistance of tubular epithelial cells to apoptosis by shRNA therapy ameliorates renal ischemia-reperfusion injury. Am J Transplant 6:2256–2267 Basnakian AG, Kaushal GP, Shah SV (2002) Apoptotic pathways of oxidative damage to renal tubular epithelial cells. Antioxid Redox Signal 4:915–924 Shirwaikar A, Malini S, Kumari SC (2003) Protective effect of Pongamia pinnata flowers against cisplatin and gentamicin induced nephrotoxicity in rats. Indian J Exp Biol 41:58–62 Juan SH, Chen CH, Hsu YH et al (2007) Tetramethylpyrazine protects rat renal tubular cell apoptosis induced by gentamicin. Nephrol Dial Transplant 22:732–739 Ray SD, Patel D, Wong V, Bagchi D (2000) In vivo protection of dna damage associated apoptotic and necrotic cell deaths during acetaminophen-induced nephrotoxicity, amiodarone-induced lung toxicity and doxorubicin-induced cardiotoxicity by a novel IH636 grape seed proanthocyanidin extract. Res Commun Mol Pathol Pharmacol 107:137–166 Al Ghamdi SS, Chatterjee PK, Raftery MJ, Thiemermann C, Yaqoob MM (2004) Role of cytochrome P4502E1 activation in proximal tubular cell injury induced by hydrogen peroxide. Ren Fail 26:103–110 Liu H, Baliga R (2003) Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis. Kidney Int 63:1687–1696 Messaris E, Antonakis PT, Memos N, Chatzigianni E, Leandros E, Konstadoulakis MM (2004) Deferoxamine administration in septic animals: improved survival and altered apoptotic gene expression. Int Immunopharmacol 4:455–459 Ramesh G, Reeves WB (2003) TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. Am J Physiol Renal Physiol 285:F610–F618 Kim YK, Choi TR, Kwon CH, Kim JH, Woo JS, Jung JS (2003) Beneficial effect of pentoxifylline on cisplatin-induced acute renal failure in rabbits. Ren Fail 25:909–922 Falk R, Hacham M, Nyska A, Foley JF, Domb AJ, Polacheck I (2005) Induction of interleukin-1beta, tumour necrosis factor-alpha and apoptosis in mouse organs by amphotericin B is neutralized by conjugation with arabinogalactan. J Antimicrob Chemother 55:713–720 Shiozaki EN, Shi Y (2004) Caspases, IAPs and Smac/DIABLO: mechanisms from structural biology. Trends Biochem Sci 29:486–494 Yang B, El Nahas AM, Fisher M et al (2004) Inhibitors directed towards caspase-1 and −3 are less effective than pan caspase inhibition in preventing renal proximal tubular cell apoptosis. Nephron Exp Nephrol 96:e39–e51 Ortiz A, Justo P, Sanz A et al (2005) Tubular cell apoptosis and cidofovir-induced acute renal failure. Antivir Ther 10:185–190 Yang W, Guastella J, Huang JC et al (2003) MX1013, a dipeptide caspase inhibitor with potent in vivo antiapoptotic activity. Br J Pharmacol 140:402–412 Cai SX, Guan L, Jia S et al (2004) Dipeptidyl aspartyl fluoromethylketones as potent caspase inhibitors: SAR of the N-protecting group. Bioorg Med Chem Lett 14:5295–5300 Tao Y, Kim J, Faubel S et al (2005) Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease. Proc Natl Acad Sci USA 102:6954–6959 Fischer U, Janicke RU, Schulze-Osthoff K (2003) Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 10:76–100 Cilenti L, Kyriazis GA, Soundarapandian MM et al (2005) Omi/HtrA2 protease mediates cisplatin-induced cell death in renal cells. Am J Physiol Renal Physiol 288:F371–F379 Jo SK, Cho WY, Sung SA, Kim HK, Won NH (2005) MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis. Kidney Int 67:458–466 Imai E, Isaka Y (2002) Targeting growth factors to the kidney: myth or reality? Curr Opin Nephrol Hypertens 11:49–57 Ramesh G, Reeves WB (2004) Inflammatory cytokines in acute renal failure. Kidney Int Suppl (91):S56–S61 Patrick DM, Leone AK, Shellenberger JJ, Dudowicz KA, King JM (2006) Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma modulate epithelial barrier function in Madin-Darby canine kidney cells through mitogen activated protein kinase signaling. BMC Physiol 6:2 Jung JY, Song JH, Li C et al (2005) Expression of epidermal growth factor in the developing rat kidney. Am J Physiol Renal Physiol 288:F227–F235 Coimbra TM, Cieslinski DA, Humes HD (1990) Epidermal growth factor accelerates renal repair in mercuric chloride nephrotoxicity. Am J Physiol 259:F438–F443 Daemen MA, van't Veer C, Denecker G et al (1999) Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 104:541–549 Varlam DE, Siddiq MM, Parton LA, Russmann H (2001) Apoptosis contributes to amphotericin B-induced nephrotoxicity. Antimicrob Agents Chemother 45:679–685 Ernst F, Hetzel S, Stracke S et al (2001) Renal proximal tubular cell growth and differentiation are differentially modulated by renotropic growth factors and tyrosine kinase inhibitors. Eur J Clin Invest 31:1029–1039 Mizui M, Isaka Y, Takabatake Y et al (2004) Electroporation-mediated HGF gene transfer ameliorated cyclosporine nephrotoxicity. Kidney Int 65:2041–2053 Kiley SC, Thornhill BA, Tang SS, Ingelfinger JR, Chevalier RL (2003) Growth factor-mediated phosphorylation of proapoptotic BAD reduces tubule cell death in vitro and in vivo. Kidney Int 63:33–42 Nishida M, Fujimoto S, Toiyama K, Sato H, Hamaoka K (2004) Effect of hematopoietic cytokines on renal function in cisplatin-induced ARF in mice. Biochem Biophys Res Commun 324:341–347 Alvarez Arroyo MV, Suzuki Y, Yague S et al (2002) Role of endogenous vascular endothelial growth factor in tubular cell protection against acute cyclosporine toxicity. Transplantation 74:1618–1624 Hiromura K, Pippin JW, Fero ML, Roberts JM, Shankland SJ (1999) Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1). J Clin Invest 103:597–604 Bukanov NO, Smith LA, Klinger KW, Ledbetter SR, Ibraghimov-Beskrovnaya O (2006) Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine. Nature 444:949–952 Price PM, Safirstein RL, Megyesi J (2004) Protection of renal cells from cisplatin toxicity by cell cycle inhibitors. Am J Physiol Renal Physiol 286:F378–F384 Charlwood J, Skehel JM, King N et al (2002) Proteomic analysis of rat kidney cortex following treatment with gentamicin. J Proteome Res 1:73–82 Amin RP, Vickers AE, Sistare F et al (2004) Identification of putative gene based markers of renal toxicity. Environ Health Perspect 112:465–479 Kramer JA, Pettit SD, Amin RP et al (2004) Overview on the application of transcription profiling using selected nephrotoxicants for toxicology assessment. Environ Health Perspect 112:460–464 Aicher L, Wahl D, Arce A, Grenet O, Steiner S (1998) New insights into cyclosporine A nephrotoxicity by proteome analysis. Electrophoresis 19:1998–2003 Bandara LR, Kelly MD, Lock EA, Kennedy S (2003) A correlation between a proteomic evaluation and conventional measurements in the assessment of renal proximal tubular toxicity. Toxicol Sci 73:195–206 Vickers AE, Rose K, Fisher R, Saulnier M, Sahota P, Bentley P (2004) Kidney slices of human and rat to characterize cisplatin-induced injury on cellular pathways and morphology. Toxicol Pathol 32:577–590 Thompson KL, Afshari CA, Amin RP et al (2004) Identification of platform-independent gene expression markers of cisplatin nephrotoxicity. Environ Health Perspect 112:488–494 Bleasby K, Hall LA, Perry JL, Mohrenweiser HW, Pritchard JB (2005) Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6). J Pharmacol Exp Ther 314:923–931 Lorz C, Justo P, Sanz A, Subira D, Egido J, Ortiz A (2004) Paracetamol-induced renal tubular injury: a role for ER stress. J Am Soc Nephrol 15:380–389 Zhang J, Clark JR Jr, Herman EH, Ferrans VJ (1996) Doxorubicin-induced apoptosis in spontaneously hypertensive rats: differential effects in heart, kidney and intestine, and inhibition by ICRF-187. J Mol Cell Cardiol 28:1931–1943 Cheng CY, Sue YM, Chen CH et al (2006) Tetramethylpyrazine attenuates adriamycin-induced apoptotic injury in rat renal tubular cells NRK-52E. Planta Med 72:888–893 Aravindan N, Cata JP, Hoffman L et al (2006) Effects of isoflurane, pentobarbital, and urethane on apoptosis and apoptotic signal transduction in rat kidney. Acta Anaesthesiol Scand 50:1229–1237 Thevenod F (2003) Nephrotoxicity and the proximal tubule. Insights from cadmium. Nephron Physiol 93:87–93 Mejia-Villet JM, Ramirez V, Cruz C, Uribe N, Gamba G, Bobadilla NA (2007) Renal ischemia/reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone. Am J Physiol Renal Physiol 293:F78–F86 Takeda M, Kobayashi M, Shirato I, Osaki T, Endou H (1997) Cisplatin-induced apoptosis of immortalized mouse proximal tubule cells is mediated by interleukin-1 beta converting enzyme (ICE) family of proteases but inhibited by overexpression of Bcl-2. Arch Toxicol 71:612–621 Takeda M, Kobayashi M, Shirato I, Endou H (1998) Involvement of macromolecule synthesis, endonuclease activation and c-fos expression in cisplatin-induced apoptosis of mouse proximal tubule cells. Toxicol Lett 94:83–92 Sheikh-Hamad D, Nadkarni V, Choi YJ et al (2001) Cyclosporine A inhibits the adaptive responses to hypertonicity: a potential mechanism of nephrotoxicity. J Am Soc Nephrol 12:2732–2741 Lantum HB, Baggs RB, Krenitsky DM, Anders MW (2002) Nephrotoxicity of chlorofluoroacetic acid in rats. Toxicol Sci 70:261–268 Hickey EJ, Raje RR, Reid VE, Gross SM, Ray SD (2001) Diclofenac induced in vivo nephrotoxicity may involve oxidative stress-mediated massive genomic DNA fragmentation and apoptotic cell death. Free Radic Biol Med 31:139–152 Creydt VP, Silberstein C, Zotta E, Ibarra C (2006) Cytotoxic effect of Shiga toxin-2 holotoxin and its B subunit on human renal tubular epithelial cells. Microbes Infect 8:410–419 Karpman D, Hakansson A, Perez MT et al (1998) Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies. Infect Immun 66:636–644 Cunningham PN, Dyanov HM, Park P, Wang J, Newell KA, Quigg RJ (2002) Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 168:5817–5823 Cunningham PN, Wang Y, Guo R, He G, Quigg RJ (2004) Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. J Immunol 172:2629–2635 Dharnidharka VR, Nadeau K, Cannon CL, Harris HW, Rosen S (1998) Ciprofloxacin overdose: acute renal failure with prominent apoptotic changes. Am J Kidney Dis 31:710–712 Duncan-Achanzar KB, Jones JT, Burke MF, Carter DE, Laird HE (1996) Inorganic mercury chloride-induced apoptosis in the cultured porcine renal cell line LLC-PK1. J Pharmacol Exp Ther 277:1726–1732 Milutinovic A, Zivin M, Zorc-Pleskovic R, Sedmak B, Suput D (2003) Nephrotoxic effects of chronic administration of microcystins -LR and -YR. Toxicon 42:281–288 Kamp HG, Eisenbrand G, Schlatter J, Wurth K, Janzowski C (2005) Ochratoxin A: induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells. Toxicology 206:413–425 Sauvant C, Holzinger H, Gekle M (2005) Proximal tubular toxicity of ochratoxin A is amplified by simultaneous inhibition of the extracellular signal-regulated kinases 1/2. J Pharmacol Exp Ther 313:234–241 Cao LC, Honeyman TW, Cooney R, Kennington L, Scheid CR, Jonassen JA (2004) Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity. Kidney Int 66:1890–1900 Duan S, Zhou X, Liu F et al (2006) Comparative cytotoxicity of high-osmolar and low-osmolar contrast media on HKCs in vitro. J Nephrol 19:717–724 Hizoh I, Strater J, Schick CS, Kubler W, Haller C (1998) Radiocontrast-induced DNA fragmentation of renal tubular cells in vitro: role of hypertonicity. Nephrol Dial Transplant 13:911–918 Garofalo AS, Borges FT, Dalboni MA, Pavao dos Santos OF (2007) Reactive oxygen species independent cytotoxicity induced by radiocontrast agents in tubular cells (LLC-PK1 and MDCK). Ren Fail 29:121–131 Itoh Y, Yano T, Sendo T et al (2006) Involvement of de novo ceramide synthesis in radiocontrast-induced renal tubular cell injury. Kidney Int 69:288–297 Lieberthal W, Fuhro R, Andry CC et al (2001) Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol 281:F693–F706 Blanco-Colio LM, Justo P, Daehn I, Lorz C, Ortiz A, Egido J (2003) Bcl-xL overexpression protects from apoptosis induced by HMG-CoA reductase inhibitors in murine tubular cells. Kidney Int 64:181–191 Loffing J, Loffing-Cueni D, Hegyi I et al (1996) Thiazide treatment of rats provokes apoptosis in distal tubule cells. Kidney Int 50:1180–1190 Markowitz GS, Fine PL, Stack JI et al (2003) Toxic acute tubular necrosis following treatment with zoledronate (Zometa). Kidney Int 64:281–289 Chen CH, Lin H, Hsu YH et al (2006) The protective effect of prostacyclin on adriamycin-induced apoptosis in rat renal tubular cells. Eur J Pharmacol 529:8–15 Schwerdt G, Freudinger R, Schuster C, Weber F, Thews O, Gekle M (2005) Cisplatin-induced apoptosis is enhanced by hypoxia and by inhibition of mitochondria in renal collecting duct cells. Toxicol Sci 85:735–742 Sheikh-Hamad D, Cacini W, Buckley AR et al (2004) Cellular and molecular studies on cisplatin-induced apoptotic cell death in rat kidney. Arch Toxicol 78:147–155 Baek SM, Kwon CH, Kim JH, Woo JS, Jung JS, Kim YK (2003) Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells. J Lab Clin Med 142:178–186 Satoh M, Kashihara N, Fujimoto S et al (2003) A novel free radical scavenger, edarabone, protects against cisplatin-induced acute renal damage in vitro and in vivo. J Pharmacol Exp Ther 305:1183–1190 Park MS, De Leon M, Devarajan P (2002) Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways. J Am Soc Nephrol 13:858–865 Davis CA, Nick HS, Agarwal A (2001) Manganese superoxide dismutase attenuates Cisplatin-induced renal injury: importance of superoxide. J Am Soc Nephrol 12:2683–2690 Kruidering M, van de WB, de Heer E, Mulder GJ, Nagelkerke JF (1997) Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. J Pharmacol Exp Ther 280:638–649 Zhang J, Duarte CG, Ellis S (1999) Contrast medium- and mannitol-induced apoptosis in heart and kidney of SHR rats. Toxicol Pathol 27:427–435 Jin QH, Zhao B, Zhang XJ (2004) Cytochrome c release and endoplasmic reticulum stress are involved in caspase-dependent apoptosis induced by G418. Cell Mol Life Sci 61:1816–1825 Cummings BS, McHowat J, Schnellmann RG (2004) Role of an endoplasmic reticulum Ca2+-independent phospholipase A2 in cisplatin-induced renal cell apoptosis. J Pharmacol Exp Ther 308:921–928 Tervahartiala P, Kivisaari L, Kivisaari R, Vehmas T, Virtanen I (1997) Structural changes in the renal proximal tubular cells induced by iodinated contrast media. Nephron 76:96–102 Humes HD, Sastrasinh M, Weinberg JM (1984) Calcium is a competitive inhibitor of gentamicin-renal membrane binding interactions and dietary calcium supplementation protects against gentamicin nephrotoxicity. J Clin Invest 73:134–147 Giuliano RA, Verpooten GA, Verbist L, Wedeen RP, De Broe ME (1986) In vivo uptake kinetics of aminoglycosides in the kidney cortex of rats. J Pharmacol Exp Ther 236:470–475 Oyama Y, Takeda T, Hama H et al (2005) Evidence for megalin-mediated proximal tubular uptake of L-FABP, a carrier of potentially nephrotoxic molecules. Lab Invest 85:522–531 Chiu PJ, Miller GH, Long JF, Waitz JA (1979) Renal uptake and nephrotoxicity of gentamicin during urinary alkalinization in rats. Clin Exp Pharmacol Physiol 6:317–326 Xiao T, Choudhary S, Zhang W, Ansari NH, Salahudeen A (2003) Possible involvement of oxidative stress in cisplatin-induced apoptosis in LLC-PK1 cells. J Toxicol Environ Health A 66:469–479 Tayem Y, Johnson TR, Mann BE, Green CJ, Motterlini R (2006) Protection against cisplatin-induced nephrotoxicity by a carbon monoxide-releasing molecule. Am J Physiol Renal Physiol 290:F789–F794 Nagothu KK, Bhatt R, Kaushal GP, Portilla D (2005) Fibrate prevents cisplatin-induced proximal tubule cell death. Kidney Int 68:2680–2693 Lee S, Kim W, Moon SO et al (2006) Rosiglitazone ameliorates cisplatin-induced renal injury in mice. Nephrol Dial Transplant 21:2096–2105 Francescato HD, Costa RS, Scavone C, Coimbra TM (2007) Parthenolide reduces cisplatin-induced renal damage. Toxicology 230:64–75 Okuda M, Masaki K, Fukatsu S, Hashimoto Y, Inui K (2000) Role of apoptosis in cisplatin-induced toxicity in the renal epithelial cell line LLC-PK1. Implication of the functions of apical membranes. Biochem Pharmacol 59:195–201 Iguchi T, Nishikawa M, Chang B et al (2004) Edaravone inhibits acute renal injury and cyst formation in cisplatin-treated rat kidney. Free Radic Res 38:333–341 Sueishi K, Mishima K, Makino K et al (2002) Protection by a radical scavenger edaravone against cisplatin-induced nephrotoxicity in rats. Eur J Pharmacol 451:203–208 Santos NA, Bezerra CS, Martins NM, Curti C, Bianchi ML, Santos AC (2007) Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria. Cancer Chemother Pharmacol 61:145–155 Lee S, Moon SO, Kim W et al (2006) Protective role of L-2-oxothiazolidine-4-carboxylic acid in cisplatin-induced renal injury. Nephrol Dial Transplant 21:2085–2095 Ikari A, Nagatani Y, Tsukimoto M, Harada H, Miwa M, Takagi K (2005) Sodium-dependent glucose transporter reduces peroxynitrite and cell injury caused by cisplatin in renal tubular epithelial cells. Biochim Biophys Acta 1717:109–117 Martinez-Salgado C, Eleno N, Morales AI, Perez-Barriocanal F, Arevalo M, Lopez-Novoa JM (2004) Gentamicin treatment induces simultaneous mesangial proliferation and apoptosis in rats. Kidney Int 65:2161–2171 Parlakpinar H, Tasdemir S, Polat A et al (2006) Protective effect of chelerythrine on gentamicin-induced nephrotoxicity. Cell Biochem Funct 24:41–48 Bledsoe G, Crickman S, Mao J et al (2006) Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis. Nephrol Dial Transplant 21:624–633 Spargias K, Alexopoulos E, Kyrzopoulos S et al (2004) Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 110:2837–2842 Itoh Y, Yano T, Sendo T, Oishi R (2005) Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media. J Pharmacol Sci 97:473–488 Gibson EM, Henson ES, Haney N, Villanueva J, Gibson SB (2002) Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release. Cancer Res 62:488–496 Liu Y, Sun AM, Dworkin LD (1998) Hepatocyte growth factor protects renal epithelial cells from apoptotic cell death. Biochem Biophys Res Commun 246:821–826 Ling H, Li X, Jha S et al (2003) Therapeutic role of TGF-beta-neutralizing antibody in mouse cyclosporin A nephropathy: morphologic improvement associated with functional preservation. J Am Soc Nephrol 14:377–388